Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug.
Introduced
Jan 9, 2025
Last Action
Jan 7, 2026
Session
NY 2025-2026
Sponsors
1 primary · 0 co
REFERRED TO INSURANCE
REFERRED TO INSURANCE
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
REFERRED TO INSURANCE